HIF1A and colorectal carcinoma: Additionally, Cu‐PrIm nanozymes could directly promote the degradation of hypoxia‐inducible factor 1α (HIF‐1α), a crucial protein involved in chemoresistance regulation,[17] thereby enhancing its cytotoxic effect on refractory chemoresistant CRC cells.